# Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's

> **NCT00736983** · PHASE3 · COMPLETED · sponsor: **Foundation for Liver Research** · enrollment: 76 (actual)

## Conditions studied

- Crohn's Disease With Perianal Fistulas

## Interventions

- **DRUG:** adalimumab
- **DRUG:** ciprofloxacin

## Key facts

- **NCT ID:** NCT00736983
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2012-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736983, "Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00736983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*